{"meshTags":["Lymphoma","Adolescent","Middle Aged","Female","Male","Skin Neoplasms","Psoriasis","Melanoma","Antineoplastic Agents","Hodgkin Disease","Neoplasms","Child","Lymphoma, Non-Hodgkin","Humans","Immunosuppression","Neoplasm Metastasis","Adult","Chemotherapy, Cancer, Regional Perfusion"],"meshMinor":["Lymphoma","Adolescent","Middle Aged","Female","Male","Skin Neoplasms","Psoriasis","Melanoma","Antineoplastic Agents","Hodgkin Disease","Neoplasms","Child","Lymphoma, Non-Hodgkin","Humans","Immunosuppression","Neoplasm Metastasis","Adult","Chemotherapy, Cancer, Regional Perfusion"],"publicationTypes":["Case Reports","Journal Article","Research Support, U.S. Gov\u0027t, P.H.S."],"abstract":"Malignant neoplasm after immunosuppressive therapy is a well-known entity. Though a considerable number of such lesions are cutaneous in origin, melanoma has rarely been reported. In this communication, six such melanoma cases are reported.","title":"Cutaneous malignant melanoma after immunosuppressive therapy.","pubmedId":"6892604"}